ARCHIVES

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

This article is from The Cancer Letter archive.

Vol. 01 No. 38 | September 19, 1975

Download PDF Visit The Full Archive

Related Articles

Aventis, MediGene In Pact For Development Of Vaccine.

February 25, 2000

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

Pathology In Operating Suite Cuts Need for More Surgery

February 24, 2012

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993